This inventor holds 33 USPTO granted patents and 26 published patent applications, plus 4 CIPO patents and 10 EPO patents, primarily in Therapeutic Nucleic Acids. Top assignees: University of Washington, Emergent Product Development Seattle,llc, Theripion, Inc.. Active years: 2006-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Shoreline, WA (US) (2006 - 2022)
- Seattle, WA (US) (2014 - 2022)
Company Filing History:
11 out of 2,173 
8 out of 11 
6 out of 6 Years Active: 2006-2025
Areas of Expertise:
Title: Innovations and Contributions of Martha Susan Hayden-Ledbetter
Introduction
Martha Susan Hayden-Ledbetter, based in Shoreline, WA, is a prominent inventor with a significant portfolio of 27 patents. Her work primarily revolves around advancements in biochemistry and molecular biology, with a focus on innovative fusion polypeptides and therapeutic applications.
Latest Patents
Among her latest inventions, she holds patents for Paraoxonase fusion polypeptides and related compositions and methods. These compositions describe bispecific molecules that incorporate biologically active polypeptides linked to paraoxonase, which serve various therapeutic functions. Furthermore, she has developed polynucleotides encoding ApoA1-PON1 fusion polypeptides, which emphasize a unique approach to therapeutics by combining different polypeptide activities. These innovations showcase her expertise in creating complex biomolecules aimed at improving health outcomes.
Career Highlights
Martha has worked with several notable organizations, including Emergent Product Development Seattle and the University of Washington. Her career in these institutions has allowed her to collaborate with leading researchers and contribute to the advancement of biomedical sciences.
Collaborations
Throughout her career, Martha has collaborated with distinguished professionals, notably Jeffrey A. Ledbetter and Keith B. Elkon. These partnerships have enriched her research and innovation efforts, resulting in impactful advancements in the field.
Conclusion
Martha Susan Hayden-Ledbetter remains a significant figure in the realm of biochemistry and molecular therapeutics. Her extensive patent portfolio reflects her innovative spirit and dedication to enhancing therapeutic techniques through her pioneering inventions. Her contributions continue to influence the landscape of scientific research and healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile